UroGen Pharma
URGN
URGN
60 hedge funds and large institutions have $111M invested in UroGen Pharma in 2022 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 9 increasing their positions, 23 reducing their positions, and 10 closing their positions.
Holders
60
Holders Change
-5
Holders Change %
-7.69%
% of All Funds
1.04%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
5
Increased
9
Reduced
23
Closed
10
Calls
$407K
Puts
$1K
Net Calls
+$406K
Net Calls Change
+$407K
Top Buyers
1 |
OM
1
Opaleye Management
Boston,
Massachusetts
|
$3.31M |
2 |
2
Ameriprise
Minneapolis,
Minnesota
|
$682K |
3 |
![]()
3
JPMorgan Chase & Co
New York
|
$438K |
4 |
4
UBS Group
Zurich,
Switzerland
|
$363K |
5 |
5
Citadel Advisors
Miami,
Florida
|
$114K |